BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Leases (Tables)

Leases (Tables)

6 Months Ended

Jun. 30, 2023

Information related to the Company’s right-of-use assets and related liabilities were as follows (in thousands):


	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2023			2022			2023			2022
Cash paid for operating lease liabilities	$	92		$	69		$	159		$	135
Right-of-use assets obtained in exchange for new operating lease obligations	$	19		$	118		$	483		$	562
Weighted-average remaining lease term	2.3 years			3.2 years			2.3 years			3.2 years
Weighted-average discount rate		12.3	%		12.3	%		12.3	%		12.3	%

Schedule of Maturities of Lease Liabilities

Maturities of lease liabilities as of June 30, 2023 for leases that have commenced are as follows (in thousands):


	June 30,
2024	$	1,056
2025		933
2026		412
2027		—
2028 and thereafter		—
Total future minimum lease obligations		2,401
Less imputed interest		(321	)
Total lease liabilities	$	2,080

Current operating lease liabilities, included in accrued liabilities	$	861
Non-current lease liabilities		1,219
Total lease liabilities	$	2,080

Future minimum rental commitments under lease agreements with non-cancelable Operating Leases

Future minimum rental commitments under lease agreements, as of June 30, 2023, with non-cancelable terms greater than one year for each of the years ending December 31 are as follows (in thousands):


	Year Ended
	December 31,
Remainder of 2023	$	532
2024		1,049
2025		817
2026		3
2027 and thereafter		—
Total future minimum lease obligations		2,401
Less imputed interest		(321	)
Total lease liabilities	$	2,080